ONCOBONE THERAPEUTICS LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Oncobone Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Oncobone Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ONCOBONE THERAPEUTICS LTD is an active private limited company (company number 13249925) incorporated on 8 March 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£101k and cash of £52k, with 3 employees on average. Net assets fell 30% on the prior period (−£78k).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
No active person with significant control is registered.
- Mr Tarquin David Fletcher Edwards
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Satu Vainikka
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 8 March 20215 yrs ago
- Next accounts due
- 30 September 2027in 337 days
- Confirmation statement due
- 22 March 2027in 145 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£101k | £52k | — | £10k | — | −£124k | 3 |
| 31 December 2024 | −£78k | £173k | — | £1,500 | — | −£38k | 3 |
| 1 January 2024 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-100,625 at 31 December 2025
- Net assets down 25% or more on the prior period-29.8% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 15.22
- Cash at bank of £50,000 or moreCash £51,668
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 8 March 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 337 days
- Confirmation statement duein 145 days
- Accounts period endNet liabilities £101k · small accounts
- Accounts period endNet liabilities £78k · small accounts
- Accounts period end
- Incorporated
Similar companies in London
- MULTIOMIC HEALTH LIMITEDLondon · inc. Mar 2021
- MEDUSA PHARMACEUTICALS LTDLondon · inc. Mar 2021
- INVOX PHARMA LIMITEDLondon · inc. Mar 2021
- SUMNER GROUP HEALTH R&D LIMITEDLondon · inc. Mar 2021
- KLEARWELL LTDLondon · inc. Mar 2021
- HCON ELEMENTS LIMITEDLondon · inc. Mar 2021
All companies incorporated on 8 March 2021 · in Mar 2021.
Reminders for ONCOBONE THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.